🎁 'Tis the season to support public service journalism Donate Now

Why Nestle lost $2.1 billion on this peanut allergy cure

Mar 21, 2023
The Swiss grocery giant bought the maker of Palforzia as part of an effort to take Nestle into the profitable health and wellness space.
Nestle CEO Mark Schneider bought the maker of Palforzia, a peanut allergy cure, as part of a pivot toward the intersection of nutrition and pharmaceuticals.
Fabrice Coffrini/Getty Images

One food industry reaping the benefits of people staying home: Peanuts

Sep 22, 2020
At home, Americans are eating a lot of peanuts. Consumption is at an all-time high.
Peanut consumption is at an all-time high during the pandemic.
Saul Loeb/AFP via Getty Images

New peanut allergy guidelines could add up for parents

Jan 5, 2017
Managing childhood food allergies carries a high cost.

You've got a new home, Charlie Brown

Apr 27, 2010
The marketing rights for Charlie Brown, Snoopy and the rest of the gang are changing hands....